Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients

International Journal of Biological Markers

Volumn 24, Issue 2, 2009, Pages 70-76

  Giaginis, Costas ^a   Margeli, Alexandra ^a   Kouraklis, Gregory ^a   Zira, Athina ^a   Tsourouflis, Gerasimos ^a   Theocharis, Stamatios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Colon cancer; Diagnosis; Prognosis; RCAS1; Serum

Indexed keywords

RECEPTOR BINDING CANCER ANTIGEN EXPRESSED ON SISO CELLS; TUMOR ANTIGEN; UNCLASSIFIED DRUG; EBAG9 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLON ADENOMA; COLON CANCER; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TUMOR DIFFERENTIATION; BIOSYNTHESIS; BLOOD; CANCER DIAGNOSIS; CASE CONTROL STUDY; COLON TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 70349780065     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2009.5545     Document Type: Article

References (39)

1. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996; 77: 1501-9.
2. Yamaguchi K, Enjoji M, Nakashima M, Nakamuta M, Watanabe T, Tanaka M. Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol 2005; 11: 5199-202.
3. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5: 938-42.
4. Matsushima T, Nakashima M, Oshima K, et al. Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001; 98: 313-21.
5. Sonoda K, Miyamoto S, Hirakawa T, et al. Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer. Gynecol Oncol 2005; 97: 772-9.
6. Sonoda K, Miyamoto S, Nakashima M, Wake N. The biological role of the unique molecule RCAS1: a bioactive marker that induces connective tissue remodeling and lymphocyte apoptosis. Front Biosci 2008; 13: 1106-16.
7. Kaku T, Sonoda K, Kamura T, et al. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res 1999; 5: 1449-53.
8. Takahashi H, Iizuka H, Nakashima M, et al. RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin. J Dermatol Sci 2001; 26: 140-4.
9. Noguchi K, Enjoji M, Nakamuta M, et al. Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma. Cancer Lett 2001; 168: 197-202.
10. Oshikiri T, Hida Y, Miyamoto M, et al. RCAS1 as a tumor progression marker: an independent negative prognostic factor in gallbladder cancer. Br J Cancer 2001; 85: 1922-7.
11. Kubokawa M, Nakashima M, Yao T, et al. Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer. Int J Oncol 2001; 19: 695-700.
12. Fukuda K, Tsujitani S, Maeta Y, Yamaguchi K, Ikeguchi M, Kaibara N. The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma. Gastric Cancer 2002; 5: 220-7.
13. Iwasaki T, Nakashima M, Watanabe T, et al. Expression and prognostic significance in lung cancer of human tumorassociated antigen RCAS1. Int J Cancer 2000; 89: 488-93.
14. Oizumi M, Nakanishi Y, Yoshino I, Nakashima M, Watanabe T, Hara N. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in non small cell lung carcinoma. Cancer 2001; 92: 446-51.
15. Suzuki T, Inoue S, Kawabata W, et al. EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrineimmune interactions. Br J Cancer 2001; 85: 1731-7.
16. Popiela TJ, Rudnicka-Sosin L, Dutsch-Wicherek M, et al. The metallothionein and RCAS1 expression analysis in breast cancer tissue regarding the immune cells presence and their activity. Neuro Endocrinol Lett 2006; 27: 786-94.
17. Kato H, Nakajima M, Masuda N, et al. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis. J Surg Oncol 2005; 90: 89-94.
18. Tsujitani S, Saito H, Oka S, et al. Prognostic significance of RCAS1 expression in relation to the infiltration of dendriric cells and lymphocytes in patients with esophageal carcinoma. Dig Dis Sci 2007; 52: 549-54.
19. Hiraoka K, Hida Y, Miyamoto M, et al. High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker. Int J Cancer 2002; 99: 418-23.
20. Giaginis C, Davides D, Zarros A, et al. Clinical significance of tumor-associated antigen RCAS1 expression in human pancreatic ductal adenocarcinoma. Dig Dis Sci 2008; 53: 1728-34.
21. Giaginis C, Giagini A, Theocharis S. Receptor-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and prognosis of human neoplasia. Histol Histopathol 2009; 24:761-76.
22. Hiraki A, Aoe K, Murakami T, et al. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma. Oncol Rep 2005; 14: 357-62.
23. Aoe K, Hiraki A, Yamazaki K, et al. Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patients. Int J Oncol 2006; 29: 65-72.
24. Akashi T, Oimomi H, Nishiyama K, et al. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer. Pancreas 2003; 26: 49-55.
25. Enjoji M, Nakamuta M, Yamaguchi K, et al. RCAS1, a useful serum marker to predict the recurrence of cancer: two cases of cholangiocarcinoma and pancreatic cancer. Dig Dis Sci 2004; 49: 1654-6.
26. Ozkan H, Akar T, Koklu S, Coban S. Significance of serum receptor-binding cancer antigen (RCAS1) in pancreatic cancer and benign pancreatobiliary diseases. Pancreatology 2006; 6: 268-72.
27. Sonoda K, Miyamoto S, Hirakawa T. Clinical significance of RCAS1 as a biomarker of uterine cancer. Gynecol Oncol 2006; 103: 924-31.
28. Sonoda K, Miyamoto S, Yotsumoto F, et al. Clinical significance of RCAS1 as a biomarker of ovarian cancer. Oncol Rep 2007; 17: 623-8.
29. Watanabe H, Enjoji M, Nakashima M, et al., Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma. J Hepatol 2003; 39: 559-63.
30. Coban S, Ozkan H, Koklu S, et al. The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers. Can J Gastroenterol 2006; 20: 593-6.
31. Midgley R, Kerr D. Colorectal cancer. Lancet 1999; 353: 391-9.
32. Trevisiol C, Di Fabio F, Nascimbeni R, et al. Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases. Int J Biol Markers 2006; 21: 223-8.
33. Riisbro R, Christensen IJ, Nielsen HJ, Brunner N, Nilbert M, Fernebro E. Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration. Int J Biol Markers 2005; 20: 93-102.
34. Okada K, Nakashima M, Komuta K, et al. Expression of tumorassociated membrane antigen, RCAS1, in human colorectal carcinomas and possible role in apoptosis of tumor-infiltrating lymphocytes. Mod Pathol 2003; 16: 679-85.
35. Leelawat K, Watanabe T, Nakajima M, Tujinda S, Suthipintawong C, Leardkamolkarn V. Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer. J Clin Pathol 2003; 56: 764-8.
36. Tsujitani S, Honboh T, Kaibara N. Immune evasion by RCAS1 in relation to the expression of cadherin family proteins in colorectal carcinoma. Biotherapy 2003; 17: 154-9.
37. Tsujitani S, Saito H, Honboh T, et al. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma. Dis Colon Rectum 2007; 50: 1241-9.
38. Green FL, Page DL, Fleming ID, et al, eds. Cancer staging manual, 6th ed. New York, NY: Springer Verlag, 2002.
39. Enjoji M, Nakashima M, Yamaguchi K, Kotoh K, Nakamuta M. Significance of RCAS1 antigen in hepatocellular, cholangiocellular and pancreatic carcinomas. J Gastroenterol Hepatol 2005; 20: 1143-8.